Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Research ArticleIUPHAR Nomenclature Report

International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers

Jean-Philippe Pin, Richard Neubig, Michel Bouvier, Lakshmi Devi, Marta Filizola, Jonathan A. Javitch, Martin J. Lohse, Graeme Milligan, Krzysztof Palczewski, Marc Parmentier and Michael Spedding
Pharmacological Reviews March 2007, 59 (1) 5-13; DOI: https://doi.org/10.1124/pr.59.1.5
Jean-Philippe Pin
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Neubig
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Bouvier
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lakshmi Devi
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Filizola
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan A. Javitch
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin J. Lohse
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme Milligan
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krzysztof Palczewski
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Parmentier
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Spedding
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 59 no. 1 5-13
DOI 
https://doi.org/10.1124/pr.59.1.5
PubMed 
17329545

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online February 28, 2007.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Jean-Philippe Pin,
  2. Richard Neubig,
  3. Michel Bouvier,
  4. Lakshmi Devi,
  5. Marta Filizola,
  6. Jonathan A. Javitch,
  7. Martin J. Lohse,
  8. Graeme Milligan,
  9. Krzysztof Palczewski,
  10. Marc Parmentier, and
  11. Michael Spedding
  1. Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Institut National de la Santé et de la Recherche Médicale U661, Université de Montpellier 1 and 2, Montpellier, France (J.-P.K.); Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (R.N.); Unité de Recherche en Pharmacologie Moléculaire, Institut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montreal, Quebec, Canada (M.B.); Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (L.D.); Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York (M.F.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, New York (J.A.J.); Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (M.J.L.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (G.M.); Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (K.P.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium (M.P.); and Institute of Research Servier, Suresnes, France (M.S.)
  1. Address correspondence to: Jean-Philippe Pin, Institut de Génomique Fonctionnelle, 141, rue de la Cardonille, 34094 Montpellier cedex 5, France. E-mail: jppin{at}igf.cnrs.fr
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2018 to November 2023

AbstractFullPdf
Jan 201811437
Feb 201866611
Mar 201858514
Apr 2018116021
May 201805817
Jun 20181416
Jul 20184499
Aug 20183299
Sep 20183308
Oct 201834017
Nov 201823115
Dec 201843107
Jan 20193955
Feb 20193522
Mar 20193080
Apr 20196075
May 20194053
Jun 20191332
Jul 20192194
Aug 201942103
Oct 20191777
Nov 20193055
Dec 20193674
Jan 20202561
Feb 20201585
Mar 20201642
May 20201020
Jun 20202763
Jul 2020921
Aug 2020421
Sep 20203721
Oct 202031172
Nov 202032610
Dec 202082959
Jan 20212639
Feb 20212398
Mar 202174716
Apr 20211289
May 20219397
Jun 202111434
Jul 202152620
Aug 20215306
Sep 20215248
Oct 20212336
Nov 202122113
Dec 20212279
Jan 20225216
Feb 20222268
Mar 20224195
Apr 20229338
May 202263917
Jun 202242811
Jul 202223115
Aug 202272216
Sep 202253613
Oct 202214311
Nov 20224419
Dec 202223511
Jan 202356011
Feb 20234211
Mar 20238548
Apr 2023101914
May 202361910
Jun 20234339
Jul 202384225
Aug 202331512
Sep 20234337
Oct 202331097
Nov 2023331114

PreviousNext
Back to top

In this issue

Pharmacological Reviews: 59 (1)
Pharmacological Reviews
Vol. 59, Issue 1
1 Mar 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleIUPHAR Nomenclature Report

International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers

Jean-Philippe Pin, Richard Neubig, Michel Bouvier, Lakshmi Devi, Marta Filizola, Jonathan A. Javitch, Martin J. Lohse, Graeme Milligan, Krzysztof Palczewski, Marc Parmentier and Michael Spedding
Pharmacological Reviews March 1, 2007, 59 (1) 5-13; DOI: https://doi.org/10.1124/pr.59.1.5

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleIUPHAR Nomenclature Report

International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers

Jean-Philippe Pin, Richard Neubig, Michel Bouvier, Lakshmi Devi, Marta Filizola, Jonathan A. Javitch, Martin J. Lohse, Graeme Milligan, Krzysztof Palczewski, Marc Parmentier and Michael Spedding
Pharmacological Reviews March 1, 2007, 59 (1) 5-13; DOI: https://doi.org/10.1124/pr.59.1.5
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Introduction
    • II. The Class C G Protein-Coupled Receptors
    • III. The Class A G Protein-Coupled Receptors
    • IV. On the Nomenclature and Recognition of Multimeric G Protein-Coupled Receptors
    • Acknowledgments
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • IUPHAR: Nuclear Receptor Pharmacology
  • Adenosine Receptors: A Further Update
  • Metabotropic Glutamate Receptors
Show more IUPHAR Nomenclature Report

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics